These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Use of diphenylhydantoin. Simpson JF Ann Intern Med; 1973 Feb; 78(2):305-6. PubMed ID: 4683770 [No Abstract] [Full Text] [Related]
8. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy. Strandjord RE; Johannessen SI Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392 [No Abstract] [Full Text] [Related]
9. [Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy]. Domzal T; Gajkowski K Neurol Neurochir Pol; 1971; 5(3):301-6. PubMed ID: 5000628 [No Abstract] [Full Text] [Related]
10. Diphenylhydantoin as an antiarrhythmic drug. Atkinson AJ; Davison R Annu Rev Med; 1974; 25():99-113. PubMed ID: 4596238 [No Abstract] [Full Text] [Related]
16. [Evaluation of the bioavailability of Polfa phenytoin tablets]. Lazowski J; Lypka A; Zadrozyńska E; Pakszys W Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430 [TBL] [Abstract][Full Text] [Related]
17. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Rizzo M; Morselli PL; Garattini S Biochem Pharmacol; 1972 Feb; 21(4):449-54. PubMed ID: 5014504 [No Abstract] [Full Text] [Related]
19. The use of blood levels of antiepileptic drugs in clinical practice. Kutt H Pediatrics; 1974 Apr; 53(4):557-60. PubMed ID: 4595906 [No Abstract] [Full Text] [Related]